Brief: Bone Therapeutics Says ALLOB Clinical Study On Track But Recruitment Slow
July 19 (Reuters) - BONE THERAPEUTICS SA BOTHE.BR :
* PROVIDES UPDATE ON THE PROGRESS OF CLINICAL STUDIES
* ALLOB PHASE IIB CURRENTLY ON TRACK BUT RECRUITMENT SLOW
DUE TO
COVID-19 PANDEMIC
* EXPECTS TO REPORT TOPLINE RESULTS FOR 3-MONTH PRIMARY
ENDPOINT
AND 6-MONTH FOLLOW-UP DATA IN FIRST HALF OF SEPTEMBER 2021
Source text for Eikon: ID:nGNE9tzWf1
Further company coverage: BOTHE.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Biosenic SA
See all newsBrief: Biosenic Says Enterprise Court Of Nivelles Approves Co's Restructuring Plan
Brief: Biosenic Anticipates Having Sufficient Cash To Carry Out Its Business Objectives Until Q3 2024
Brief: BioSenic Patent Granted In Canada For Broader Protection Of ATO Therapeutic Platform
Brief: Biosenic Files For Additional Patent Protection For Osteoarthritis Drug
Brief: BioSenic Signs New Binding Term Sheet With Phebra PTY Ltd